BioSpace News Archive

Biotech Beach

Ionis’ antisense therapies in ATTR amyloidosis to be featured at 2021 PNS Annual Meeting

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced that multiple presentations highlighting advances in its ATTR amyloidosis programs will be featured during the 2021 Peripheral Nerve Society (PNS) Annual Meeting to be held virtually on June 12-13, and 25-27, 2021.

June 10, 2021
·
4 min read
Business

Eargo Appoints Katie Bayne to Board of Directors

Eargo, Inc., a medical device company on a mission to improve the quality of life of people with hearing loss, announced the appointment of Katie Bayne to its Board of Directors, effective June 9, 2021.

June 10, 2021
·
5 min read
BioMidwest

Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders

Clovis Oncology, Inc. announced partial results and the partial adjournment of its 2021 Annual Meeting of Stockholders.

June 10, 2021
·
3 min read
Drug Development

Precigen ActoBio Announces Positive Topline Results from Phase 1b/2a Study of AG019 ActoBiotics™, A Novel Therapy Designed to Address the Underlying Cause of Type 1 Diabetes

Precigen ActoBio, an innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents and a wholly-owned subsidiary of Precigen, Inc. (Nasdaq: PGEN), today announced positive topline results for the ongoing Phase 1b/2a clinical study investigating AG019 ActoBiotics™ for the treatment of recent-onset type 1 diabetes (T1D)

June 10, 2021
·
11 min read